Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register June 24, 2026. Document 2026-12654. Updated Nov. 9, 2026.
- What it does
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle O-DSMT.
The Drug Enforcement Administration's summary, as published in the Federal Register.
- What changed in the regulation
1 part of Title 21 of the Code of Federal Regulations:
- Compared with
The Drug Enforcement Administration has published 26 final rules in 2026 so far, compared with 17 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
June 24, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2026-12654 |
|---|---|
| Action | Proposed amendment; notice of intent. |
| Agencies | Justice Department; Drug Enforcement Administration |
| Published | June 24, 2026 |
| Docket | DEA-2026-0958 |
Source: the Federal Register (public domain). The document in the Federal Register